1. Home
  2. GH vs RUSHA Comparison

GH vs RUSHA Comparison

Compare GH & RUSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.88

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Rush Enterprises Inc. Cl A

RUSHA

Rush Enterprises Inc. Cl A

HOLD

Current Price

$54.90

Market Cap

4.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
RUSHA
Founded
2011
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
4.0B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
GH
RUSHA
Price
$101.88
$54.90
Analyst Decision
Strong Buy
Buy
Analyst Count
21
2
Target Price
$79.19
$58.00
AVG Volume (30 Days)
2.4M
707.7K
Earning Date
10-29-2025
10-29-2025
Dividend Yield
N/A
1.38%
EPS Growth
N/A
N/A
EPS
N/A
3.37
Revenue
$902,569,000.00
$7,671,888,000.00
Revenue This Year
$34.72
N/A
Revenue Next Year
$26.46
$6.33
P/E Ratio
N/A
$16.29
Revenue Growth
30.38
N/A
52 Week Low
$29.91
$45.67
52 Week High
$112.43
$65.43

Technical Indicators

Market Signals
Indicator
GH
RUSHA
Relative Strength Index (RSI) 56.90 69.39
Support Level $103.36 $46.41
Resistance Level $109.59 $55.35
Average True Range (ATR) 5.54 1.32
MACD -1.11 0.71
Stochastic Oscillator 42.83 95.02

Price Performance

Historical Comparison
GH
RUSHA

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About RUSHA Rush Enterprises Inc. Cl A

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

Share on Social Networks: